Literature DB >> 2509805

Prospects for gene therapy now and in the future.

R J Akhurst1.   

Abstract

Advances in gene technology and cell biology have supplied the means to undertake human gene therapy in the near future. Techniques have been developed for the efficient introduction of gene sequences into the pluripotential stem cells of the haematopoietic system and our increased understanding of gene-regulatory mechanisms should allow therapeutic gene expression levels to be obtained. Gene therapy should, at present, be termed gene supplementation since it will involve the addition of corrective genes to the host cell genome. It may only be used to treat recessively inherited disorders. Prospects for the future include the use of homologous recombination to correct or replace defective genes, allowing the treatment of dominantly inherited diseases.

Entities:  

Mesh:

Year:  1989        PMID: 2509805     DOI: 10.1007/bf01799294

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  19 in total

1.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

2.  Gene therapy. Desperate appliances.

Authors:  M Robertson
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

3.  Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene.

Authors:  K R Thomas; M R Capecchi
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

4.  Developmental potential and dynamic behavior of hematopoietic stem cells.

Authors:  I R Lemischka; D H Raulet; R C Mulligan
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

5.  Construction of a defective retrovirus containing the human hypoxanthine phosphoribosyltransferase cDNA and its expression in cultured cells and mouse bone marrow.

Authors:  S M Chang; K Wager-Smith; T Y Tsao; J Henkel-Tigges; S Vaishnav; C T Caskey
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

6.  The ethics of human gene therapy.

Authors:  L Walters
Journal:  Nature       Date:  1986 Mar 20-26       Impact factor: 49.962

7.  Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo.

Authors:  D A Williams; S H Orkin; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

9.  Position-independent, high-level expression of the human beta-globin gene in transgenic mice.

Authors:  F Grosveld; G B van Assendelft; D R Greaves; G Kollias
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

10.  Expression of a myelin basic protein gene in transgenic shiverer mice: correction of the dysmyelinating phenotype.

Authors:  C Readhead; B Popko; N Takahashi; H D Shine; R A Saavedra; R L Sidman; L Hood
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

View more
  2 in total

Review 1.  Gene therapy on renal-cell carcinoma: magic bullet or tragic insanity?

Authors:  G H Mickisch
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

Review 2.  From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists.

Authors:  G H Mickisch; F H Schroeder
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.